Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$52.3M |
| 2 |
Exelon
EXC
|
+$51.9M |
| 3 |
Linde
LIN
|
+$48.3M |
| 4 |
Advanced Micro Devices
AMD
|
+$41.5M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$251M |
| 2 |
Microsoft
MSFT
|
+$235M |
| 3 |
Amazon
AMZN
|
+$226M |
| 4 |
CoStar Group
CSGP
|
+$103M |
| 5 |
AerCap
AER
|
+$82.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.96% |
| 2 | Industrials | 12.92% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Financials | 9.27% |
| 5 | Energy | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Marriott Vacations Worldwide
VAC
$3.93B
| $1.12M | 0.01% |
7,120
+3,930
| +123% | +$632K |
|
1077
Sarepta Therapeutics
SRPT
$1.92B
| $1.12M | 0.01% |
14,368
-1,196
| -8% | -$91.6K |
|
|
RDNW
1078
RideNow Group
RDNW
$231M
| $1.12M | 0.01% |
32,663
+23,294
| +249% | +$785K |
|
|
SI
1079
DELISTED
Silvergate Capital Corporation
SI
| $1.11M | 0.01% |
7,406
-7,263
| -50% | -$898K |
|
1080
Tenaris
TS
$27B
| $1.11M | 0.01% |
37,063
-7,975
| -18% | -$207K |
|
|
NSA
1081
DELISTED
National Storage Affiliates Trust
NSA
| $1.11M | 0.01% |
17,740
-12,876
| -42% | -$792K |
|
1082
NIO
NIO
$10.9B
| $1.11M | 0.01% |
+52,808
| New | +$1.24M |
|
1083
Archer Aviation
ACHR
$4.67B
| $1.11M | 0.01% |
230,914
+215,827
| +1,431% | +$793K |
|
1084
Nerdy
NRDY
$87.7M
| $1.11M | 0.01% |
14,548
+11,150
| +328% | +$746K |
|
|
TCDA
1085
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.11M | 0.01% |
134,857
+95,258
| +241% | +$862K |
|
|
MRSN
1086
DELISTED
Mersana Therapeutics
MRSN
| $1.11M | 0.01% |
11,084
+9,868
| +812% | +$1.15M |
|
|
VORB
1087
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
| $1.1M | 0.01% |
+151,406
| New | +$1.1M |
|
1088
PVH
PVH
$3.55B
| $1.1M | 0.01% |
14,391
-107,108
| -88% | -$9.92M |
|
1089
Danaos Corp
DAC
$2.74B
| $1.09M | 0.01% |
+10,662
| New | +$970K |
|
1090
Simon Property Group
SPG
$71.4B
| $1.09M | 0.01% |
+8,259
| New | +$1.18M |
|
|
CMAX
1091
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $1.09M | 0.01% |
4,851
+2,614
| +117% | +$542K |
|
1092
Rush Enterprises Class A
RUSHA
$8.53B
| $1.09M | 0.01% |
32,012
+4,605
| +17% | +$162K |
|
1093
Blue Ridge Bankshares
BRBS
$352M
| $1.08M | 0.01% |
71,426
-7,044
| -9% | -$118K |
|
1094
Rambus
RMBS
$9.44B
| $1.08M | 0.01% |
33,928
+14,792
| +77% | +$409K |
|
1095
Information Services Group
III
$241M
| $1.08M | 0.01% |
158,677
+77,931
| +97% | +$549K |
|
|
SCHW
1096
Charles Schwab
SCHW
$197B
| $1.08M | 0.01% |
+12,822
| New | +$1.13M |
|
|
SAFE
1097
Safehold
SAFE
$1.1B
| $1.08M | 0.01% |
9,462
+5,246
| +124% | +$614K |
|
1098
Supernus Pharmaceuticals
SUPN
$2.62B
| $1.08M | 0.01% |
33,343
-2,527
| -7% | -$77.5K |
|
|
IEA
1099
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $1.08M | 0.01% |
90,826
-41,662
| -31% | -$446K |
|
1100
Inspired Entertainment
INSE
$159M
| $1.07M | 0.01% |
+87,202
| New | +$1.17M |
|
Similar funds
Michael Gelband's Q1 2022 Portfolio in Review
As of Q1 2022, Michael Gelband held 2,902 positions worth $7.91B, down 18% from $9.67B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Michael Gelband withdrew a net $1.37B in Q1 2022, closing 758 positions and reducing 576 holdings. Its most notable exit was CoStar Group, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Michael Gelband opened a new position in Linde worth $49.9M.
- Michael Gelband's largest Q1 2022 buy was Linde: 156,289 shares worth $49.9M.
- Michael Gelband added most to ExxonMobil in Q1 2022, an estimated $52.3M increase.
- Michael Gelband's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $251M.
- Michael Gelband fully exited CoStar Group in Q1 2022, selling an estimated $103M.
- Michael Gelband's ten largest holdings make up 11% of its $7.91B portfolio in Q1 2022.
- Michael Gelband opened 788 new positions and closed 758 in Q1 2022.
- Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.91B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.